U.S. FDA changes course and agrees to review Moderna's mRNA flu vaccine application

2026-02-18 - 14:43

Moderna says the U.S. Food and Drug Administration (FDA) has agreed to review its influenza ‌vaccine, reversing an earlier decision to reject the application, following modifications from the company.